phase readout
saveNCT04126070: Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
ACTIVE_NOT_RECRUITINGupdated 17m ago
community read0 votes
Sponsor: Xiao X. Wei, MD. Phase: PHASE2. Conditions: Hormone Sensitive Prostate Cancer, Prostate Adenocarcinoma, Metastasis Prostate Adenocarcinoma
view source ↗
comments(0)
5-min edit window · permanent after that